BioLineRx (BLRX) Plans Offering of ADSs and Warrants

February 4, 2019 4:43 PM

BioLineRx (NASDAQ: BLRX) a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has commenced an underwritten ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found